0

ent-Montelukast Sodium Salt

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAPS190078456
CAS190078-45-6
SynonymsCyclopropaneacetic acid, 1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, monosodium salt, [S-(E)]-, L 768232, Cyclopropaneacetic acid, 1-[[[(1S)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, monosodium salt (9CI), (S)-Montelukast, ent-Montekulast Sodium Salt, Montelukast Sodium Imp. A (EP) as Sodium Salt,Cyclopropaneacetic acid, 1-[[[(1S)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, sodium salt (1:1)
IUPAC Namesodium;2-[1-[[(1S)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetate
Molecular Weight608.17
Molecular FormulaC35H35ClNO3S.Na
Canonical SMILES[Na+].CC(C)(O)c1ccccc1CC[C@H](SCC2(CC(=O)[O-])CC2)c3cccc(\C=C\c4ccc5ccc(Cl)cc5n4)c3
InChIInChI=1S/C35H36ClNO3S.Na/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29;/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39);/q;+1/p-1/b15-10+;/t32-;/m0./s1
Accurate Mass607.1924
FormatNeat
Product TypeImpurity
  • Verification code
CATSizeShippingStorage ConditionsDescription
APS190078456-10MG 10MG Room Temperature 2-8°C Fridge/Coldroom Subcategory: Pharmaceutical, Chiral molecules, Impurity standards Inquiry
APS190078456-5MG 5MG Room Temperature 2-8°C Fridge/Coldroom Subcategory: Impurity standards, Chiral molecules Inquiry
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode
Privacy Policy | Cookie Policy | Copyright © 2024 Alfa Chemistry. All rights reserved.